Project Grant R21EB038444
- Federal Grant Award Summary Massachusetts Institute of Technology (MIT) received a $514,357 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, dated June 1, 2025, with completion expected by May 31, 2029, supports the development and prototype demonstration of a portable, liquid-helium-free 1-Tesla/560-millimeter room-temperature...
- Federal Project Grant Award Summary Northeastern University received a $673,600 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025, through July 31, 2028. The award supports development of programmable RNA-based sensors that detect integrated changes in both messenger RNA (mRNA) and microRNA (miRNA) to enable in...
- Federal Project Grant Award Summary Northeastern University received a $394,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award supports the development of quantum sensor-enhanced magnetic resonance techniques to advance biophysical research capabilities. Specifically, the project aims to integrate nitrogen-vacancy (NV) centers...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Boston Children's Hospital a $996,466 Project Grant effective August 1, 2025, through May 31, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). This award supports the development of motion- and distortion-robust quantitative magnetic resonance imaging (QMRI) technology designed to enable advanced in-vivo analysis of...
- Federal Grant Award Summary The University of Minnesota received a $531,021 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective April 10, 2026, with a completion date of January 31, 2030. This award supports technology development to advance ultrahigh-field magnetic resonance imaging (MRI) capabilities at 10.5 Tesla,...
- Federal Project Grant Award Summary Northwestern University received a $170,198 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded on September 15, 2025, with completion by August 31, 2027. The research addresses a critical clinical gap by developing vertical MRI (magnetic resonance imaging) technology to safely image children...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the Trustees of Boston University a Project Grant of $613,124 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 15, 2025, through July 31, 2028. The project delivers the development and demonstration of Quantitative Phase Imaging Meta-Sensors (PIMSs)—advanced optical imaging sensors that...
- Federal Project Grant Award Summary The University of Michigan received a $149,264 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective March 26, 2026, with completion targeted for November 30, 2027. The award supports development of magnetic resonance (MR) fingerprinting technology specifically optimized for cardiac magnetic...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering awarded The Johns Hopkins University a $477,360 Project Grant on August 14, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to enhance the robustness and accessibility of open-source, vendor-neutral magnetic resonance imaging (MRI) technology through the Pypulseq platform. The project, concluding July 31, 2027, delivers three...
- Federal Grant Award Summary Northeastern University received a $788,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with completion targeted by May 31, 2030. The award supports research development and validation of engineered macrophages equipped with multi-modal imaging markers detectable via ultrasound, magnetic resonance imaging (MRI), and optical imaging to...
Northeastern University received a $219,818 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), with performance in Boston, Massachusetts from April 27, 2026 through January 31, 2029. The project focuses on developing a fully integrated electro-optic sensor system designed to enable real-time magnetic resonance imaging (MRI)-guided interventions. This technology addresses a critical clinical need by creating a safer, more effective alternative to current X-ray fluoroscopy-based image guidance systems that expose patients to ionizing radiation and provide limited soft tissue contrast. The core deliverable involves engineering an interventional device—such as a catheter or needle—that achieves safe and effective visibility under MRI without the radiofrequency (RF)-induced heating hazards that have limited clinical adoption of existing active tracking devices. By eliminating long conductive transmission lines and leveraging electro-optic sensing mechanisms, the technology is intended to provide superior signal-to-noise ratios while maintaining patient safety at high magnetic field strengths (3 Tesla and above). The development of this clinical-grade device would substantially advance minimally invasive, image-guided procedures for treating cardiovascular disease, cancer, and other major medical conditions while reducing procedural risks, recovery times, and radiation exposure.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $219.8k | 4/28/26 |